TUBERCULOSIS, LATENT

Clinical trials for TUBERCULOSIS, LATENT explained in plain language.

Never miss a new study

Get alerted when new TUBERCULOSIS, LATENT trials appear

Sign up with your email to follow new studies for TUBERCULOSIS, LATENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Four-Week pill could revolutionize TB prevention for millions at risk

Prevention Not yet recruiting

This study aims to see if a 4-week course of the drug bedaquiline is as safe and effective as standard, longer drug regimens at preventing active tuberculosis (TB). It will enroll over 2500 people living with HIV and close contacts of people with TB who are at high risk of develo…

Matched conditions: TUBERCULOSIS, LATENT

Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Prevention

Last updated Mar 23, 2026 15:18 UTC

TUBERCULOSIS, LATENT

Get alerted when new TUBERCULOSIS, LATENT trials appear

Four-Week pill could revolutionize TB prevention for millions at risk